MedTech Terms
    The authoritative reference
    All terms
    Investment & FinanceStartup Lifecycle

    Milestone Payment

    Contingent payment triggered by a defined event in a partnership, M&A, or financing.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Milestone payments - common in licensing deals and acquisitions - release capital upon defined regulatory (e.g., PMA approval), clinical (e.g., enrollment), or commercial (e.g., sales thresholds) milestones.
    What the regulation says
    While milestone payments are primarily a financial construct, regulatory approvals are frequently designated as milestones. For example, a payment might be contingent upon obtaining a 510(k) clearance or a Premarket Approval (PMA) from the FDA, or a CE Mark under the EU Medical Device Regulation (EU MDR). These regulatory achievements directly impact a MedTech product's market access and commercial viability, thus serving as critical junctures for financial disbursements in agreements.

    What this means in practice

    Deal value often hinges on milestone structure: heavy back-end milestones reduce upfront risk for the acquirer but defer founder/investor proceeds.

    Examples

    • A licensing agreement stipulates a $10 million payment to the licensor upon the FDA granting Premarket Approval (PMA) for the licensed Class III diagnostic device.
    • An acquisition deal includes a clause for an additional $5 million to the acquired company's founders once their novel robotic surgical system receives a CE Mark under the EU MDR, allowing it to be marketed in Europe.
    • A development contract specifies a payment upon successful submission of a 510(k) premarket notification to the FDA for a new medical imaging device, demonstrating progress toward market authorization.
    Common pitfalls
    • •Misinterpreting regulatory milestones can lead to significant financial and project timeline discrepancies.
    • •Failing to clearly define the exact regulatory event triggering a payment can result in disputes between parties.
    • •Overlooking the potential for regulatory delays to impact milestone payment schedules is a common mistake.
    • •Assuming regulatory submissions alone, rather than final approvals, constitute a payment milestone can create confusion.

    Frequently asked questions

    Regulatory milestones are tied to approvals or clearances from authorities like the FDA or a Notified Body, while clinical milestones relate to progress in human studies, such as patient enrollment completion or successful interim trial results.

    Cross-references

    Used by

    Things that build on this term.

    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    BIO·1PitchBook·1NVCA·1
    1. 1
      BIO Deal Database
      Verified
      BIObio.org
    2. 2
      PitchBook - MedTech Coverage
      Verified
      PitchBookpitchbook.com
    3. 3
      NVCA Model Documents
      Verified
      NVCAnvca.org

    Inline markers like [1] jump to the matching reference above.